EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer

DOI: 10.1080/2162402X.2017.1356145

Keywords: EGFR, mutation burden, non-small cell lung cancer, programmed cell death protein-1, uninflamed

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text